Chief Executive and Scientific Officer, Sanaria Inc.
CEO and Chief Scientific Officer, Fina BioSolutions
CEO
sAAVient Therapeutics
Senior Advisor, Vaccine Research & Development, GSK
Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital
Professor of Theoretical Epidemiology, Department of Biology, University of Oxford, UK
Director, National Emerging Infectious Diseases Laboratories (NEIDL), Boston University
Biology of Viral Emerging Infections, Institut Pasteur, France
Professor, Department of Molecular Medicine, Morsani College of Medicine, University of South Florida
Professor, Disease Intervention and Prevention, Texas Biomedical Research Institute
Shahin Gharakhanian MD Consulting LLC, Cambridge Innovation Center
Professor, Hebei University of Technology, Brown University, and Saveetha University
Director, Center for Operations Research in Medicine and Healthcare, Morehouse School of Medicine
Professor and Vice Chair, W. Harry Feinstone Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health
Distinguished Professor of Virology and Vaccinology, Galveston National Laboratory, University of Texas Medical Branch
Founder and CEO, Zola Therapeutics; Adjunct Professor, UMass Chan Medical School RNA Therapeutics Institute
Chief, Department of Virus-Host Interactions, Viral Diseases Branch, Walter Reed Army Institute of Research